Plasma shows distinct metabolomic and proteomic signatures in response to combination therapy with lenvatinib and anti-programmed death-1 (PD-1) antibody in treating hepatocellular carcinoma (HCC). Here, we present a protocol for analyzing plasma proteomes from patients with HCC receiving combination therapy. We describe steps for interpreting mass spectrometry data by database searching using MaxQuant and filtering and processing database search outcomes.
View Article and Find Full Text PDFDentritic cells (DCs) dysfunction has been verified detrimental for sepsis and B and T lymphocyte attenuator (BTLA) is an immune-regulatory receptor shown to be associated with DCs dysfunction. However, the role of BTLA expression in myeloid DCs (mDCs) in neonatal sepsis is unknown. In the current study, we found BTLA-expressing mDCs were elevated in neonates with sepsis and the BTLA expression level in mDCs was positively correlated to the severity of sepsis.
View Article and Find Full Text PDFGuang Pu Xue Yu Guang Pu Fen Xi
December 2015